Close Menu

NEW YORK (GenomeWeb) – With the first placements of its Shahky exosome analysis instrument, Exosome Diagnostics is moving into protein detection.

To date, the company has focused on the measurement of exosomal nucleic acids along with cell-free DNA, but the development of the Shahky system will allow it to explore protein detection as a tool for both its pharma customers and internal diagnostic development efforts.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.